1. Home
  2. ORLA vs IRTC Comparison

ORLA vs IRTC Comparison

Compare ORLA & IRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Orla Mining Ltd.

ORLA

Orla Mining Ltd.

HOLD

Current Price

$9.79

Market Cap

4.5B

ML Signal

HOLD

Logo iRhythm Technologies Inc.

IRTC

iRhythm Technologies Inc.

HOLD

Current Price

$116.15

Market Cap

3.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ORLA
IRTC
Founded
2007
2006
Country
Canada
United States
Employees
N/A
N/A
Industry
Precious Metals
Medical/Dental Instruments
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.5B
3.9B
IPO Year
2016
2016

Fundamental Metrics

Financial Performance
Metric
ORLA
IRTC
Price
$9.79
$116.15
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
13
Target Price
$21.00
$197.92
AVG Volume (30 Days)
3.3M
578.3K
Earning Date
05-08-2026
04-30-2026
Dividend Yield
0.12%
N/A
EPS Growth
N/A
61.71
EPS
N/A
N/A
Revenue
N/A
$747,138,000.00
Revenue This Year
$63.44
$19.60
Revenue Next Year
N/A
$15.94
P/E Ratio
$107.37
N/A
Revenue Growth
N/A
26.24
52 Week Low
$9.15
$100.85
52 Week High
$21.98
$210.01

Technical Indicators

Market Signals
Indicator
ORLA
IRTC
Relative Strength Index (RSI) 40.55 48.74
Support Level $9.62 $111.37
Resistance Level $10.50 $121.88
Average True Range (ATR) 0.41 5.75
MACD 0.10 0.44
Stochastic Oscillator 46.10 50.59

Price Performance

Historical Comparison
ORLA
IRTC

About ORLA Orla Mining Ltd.

Orla Mining Ltd is a mineral exploration company. It is engaged in the acquisition and exploration of mineral properties. The company holds three gold projects: the Camino Rojo gold and silver project in Zacatecas State, the Musselwhite gold mine project located in Ontario and the South Railroad projects in Nevada, USA, and the Cerro Quema gold project in Panama. It conducts business activities in Mexico, Panama, the United States, and Canada.

About IRTC iRhythm Technologies Inc.

iRhythm Holdings Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.

Share on Social Networks: